Assessing the risk of concurrent mycoplasma pneumoniae pneumonia in children with tracheobronchial tuberculosis: retrospective study

被引:0
|
作者
Liu, Lin [1 ]
Jiang, Jie [1 ]
Wu, Lei [1 ]
Zeng, De miao [2 ]
Yan, Can [1 ]
Liang, Linlong [1 ]
Shi, Jiayun [1 ]
Xie, Qifang [1 ]
机构
[1] Univ South China, Affiliated Changsha Cent Hosp, Hengyang Med Sch, Dept Pediat, Changsha, Hunan, Peoples R China
[2] Kunming Med Univ, Southern Cent Hosp Yunnan Prov, Peoples Hosp Honghe State 1, Dept Joint Surg,HeHonghe Affiliated Hosp, Changsha, Hunan, Peoples R China
来源
PEERJ | 2024年 / 12卷
关键词
Machine learning; Extreme gradient boosting; Child; Tuberculosis; Tracheobronchial; Pneumonia; Mycoplasma;
D O I
10.7717/peerj.17164
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: This study aimed to create a predictive model based on machine learning to identify the risk for tracheobronchial tuberculosis (TBTB) occurring alongside Mycoplasma pneumoniae pneumonia in pediatric patients. Methods: Clinical data from 212 pediatric patients were examined in this retrospective analysis. This cohort included 42 individuals diagnosed with TBTB and Mycoplasma pneumoniae pneumonia (combined group) and 170 patients diagnosed with lobar pneumonia alone (pneumonia group). Three predictive models, namely XGBoost, decision tree, and logistic regression, were constructed, and their performances were assessed using the receiver's operating characteristic (ROC) curve, precision-recall curve (PR), and decision curve analysis (DCA). The dataset was divided into a 7:3 ratio to test the first and second groups, utilizing them to validate the XGBoost model and to construct the nomogram model. Results: The XGBoost highlighted eight significant signatures, while the decision tree and logistic regression models identified six and five signatures, respectively. The ROC analysis revealed an area under the curve (AUC) of 0.996 for XGBoost, significantly outperforming the other models (p < 0.05). Similarly, the PR curve demonstrated the superior predictive capability of XGBoost. DCA further confirmed that XGBoost offered the highest AIC (43.226), the highest average net benefit (0.764), and the best model fit. Validation efforts confirmed the robustness of the findings, with the validation groups 1 and 2 showing ROC and PR curves with AUC of 0.997, indicating a high net benefit. The nomogram model was shown to possess significant clinical value. Conclusion: Compared to machine learning approaches, the XGBoost model demonstrated superior predictive efficacy in identifying pediatric patients at risk of concurrent TBTB and Mycoplasma pneumoniae pneumonia. The model's identification of critical signatures provides valuable insights into the pathogenesis of these conditions.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] SPECTRUM OF MYCOPLASMA-PNEUMONIAE PNEUMONIA IN CHILDREN
    GAMBERT, C
    WERNER, E
    DEKERDANET, M
    MONGINET, F
    BRUEL, H
    JEZEQUEL, C
    PEDIATRIE, 1993, 48 (03): : 241 - 247
  • [32] Clinical value of monitoring cytokine levels for assessing the severity of mycoplasma pneumoniae pneumonia in children
    Han, Qian
    Jiang, Tingting
    Wang, Tianyi
    Wang, Dongmeng
    Tang, He
    Chu, Yongtao
    Bi, Jing
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (08): : 3964 - 3977
  • [33] Chest CT Findings and Differential Diagnosis of Mycoplasma pneumoniae Pneumonia and Mycoplasma pneumoniae Combined with Streptococcal Pneumonia in Children
    Wang, Jing
    Xia, Chen
    Sharma, Ashutosh
    Gaba, Gurjot Singh
    Shabaz, Mohammad
    JOURNAL OF HEALTHCARE ENGINEERING, 2021, 2021
  • [34] The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children
    Zheng, Baoying
    Zhao, Jing
    Cao, Ling
    BMC INFECTIOUS DISEASES, 2020, 20 (01)
  • [35] Clinical characteristics and risk factors of pulmonary embolism with Mycoplasma pneumoniae pneumonia in children
    Zhang, Xue
    Sun, Ruiyang
    Hou, Jiapu
    Jia, Wanyu
    Li, Peng
    Song, Chunlan
    Cheng, Yibing
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] Risk factors for delayed radiographic resolution in children with refractory Mycoplasma pneumoniae pneumonia
    Yan, Qiuli
    Niu, Wensi
    Jiang, Wujun
    Hao, Chuangli
    Chen, Meiyuan
    Hua, Jun
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (05)
  • [37] Safety study of moxifloxacin in children with severe refractory Mycoplasma pneumoniae pneumonia
    He, Yu-Shan
    Yang, Mei
    Liu, Gang
    Ji, Jian
    Qian, Su-Yun
    PEDIATRIC PULMONOLOGY, 2023, 58 (07) : 2017 - 2024
  • [38] Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia A retrospective study
    Lan, Yinle
    Li, Shuxian
    Yang, Dehua
    Zhou, Junfen
    Wang, Yingshuo
    Wang, Jianhua
    Xu, Yingchun
    Chen, Zhimin
    MEDICINE, 2020, 99 (19) : E19987
  • [39] Risk factors for suspected pulmonary embolism in children: Complication of Mycoplasma pneumoniae pneumonia
    Gu, Hui
    Li, Bowen
    Han, Yicheng
    Yang, Shifeng
    Wang, Ximing
    EUROPEAN JOURNAL OF RADIOLOGY, 2024, 176
  • [40] Prediction of risk factors of bronchial mucus plugs in children with Mycoplasma pneumoniae pneumonia
    Jiahui Zhang
    Ting Wang
    Rongrong Li
    Wei Ji
    Yongdong Yan
    Zhichao Sun
    Jiahong Tan
    Jinfeng Wu
    Li Huang
    Zhengrong Chen
    BMC Infectious Diseases, 21